What Is Immunotherapy – and Is It Right for You?
If you or a loved one has been diagnosed with cancer, doctors can choose from many treatments to provide the
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
If you or a loved one has been diagnosed with cancer, doctors can choose from many treatments to provide the
A new study shows that the benefits of receiving cancer care close to home extend beyond the obvious quality-of-life advantages
A colon cancer diagnosis can trigger new and difficult emotions. As the disease’s symptoms progress, you may also experience changes
One of the newest cancer treatment methods offered at Regional Cancer Care Associates is targeted therapy. For some patients, targeted
When the National Cancer Institute (NCI) accorded the John Theurer Cancer Center (JTCC), part of Hackensack Meridian HealthHackensack University Medical
RCCA MSO LLC (“RCCA MSO”), the management services entity for Regional Cancer Care Associates LLC (“RCCA”) and RCCA MD LLC
The way cancer is treated is changing. Physicians will soon approach a patient’s cancer the same way they approach a
Just over 100,000 Americans will be diagnosed with colon cancer this year, while another 44,000 will be diagnosed with cancer
Ann Walsh, Nurse at Regional Cancer Care Associates is being honored with The DAISY Award for Extraordinary Nurses ®. The
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.